You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
抗疫概念股领涨港A市场 全球新冠确诊病例超1675万例
格隆汇 07-29 12:52
格隆汇7月29日丨港A市场抗疫概念股再度全线爆发。A股市场上,血液制品、生物疫苗、基因检测、医疗器械等板块全线走高,个股方面,天坛生物、双林生物、博晖创新、安科生物、贝瑞基因、智飞生物、共进股份等超10股涨停;港股市场上,生物医药和医疗保健设备板块领涨,其中,康希诺生物涨近13%,爱康医疗和微创医疗均涨近5%。全球新冠肺炎新增数据继续呈高增长态势。美国约翰斯·霍普金斯大学数据显示,截至北京时间29日8时55分,全球(中国以外)新冠确诊病例超1675万例,较前一日增加23.3万例,死亡病例累计超65.6例,较前一日增加6309例。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account